 |
|
Preventing Influenza in Healthy Adults
The Evolving Story
Arnold S. Monto, MD
JAMA. 2000;284:1699-1701.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Inactivated influenza vaccine was originally developed during World War II to protect healthy adult members of the United States armed services. With its major interest in preventing influenza to maintain military readiness, the US military conducted a large number of randomized controlled trials from 1943 through 1969, which demonstrated that the vaccine was 70% to 90% efficacious in preventing laboratory-confirmed clinical influenza as long as the virus in the vaccine resembled the virus that was circulating.1 The current influenza vaccine is similar to the vaccines used in those trials, with higher potency and fewer adverse events. Its efficacy in healthy adults was recently reconfirmed in a randomized trial in which efficacy against laboratory-confirmed influenza was 88%.2
Recommendations for use of influenza vaccine in the United States for years have emphasized prevention of influenza in persons most likely to experience complications: those aged 65 years or older . . . [Full Text of this Article]
Author Affiliation: School of Public Health, University of Michigan, Ann Arbor, Mich.
RELATED ARTICLE
Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial
Carolyn Buxton Bridges, William W. Thompson, Martin I. Meltzer, Gordon R. Reeve, Walter J. Talamonti, Nancy J. Cox, Heather A. Lilac, Henrietta Hall, Alexander Klimov, and Keiji Fukuda
JAMA. 2000;284(13):1655-1663.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Influenza
Cifu and Levinson
JAMA 2000;284:2847-2849.
FULL TEXT
Should Healthy Individuals Receive Influenza Immunization?
JWatch Infect. Diseases 2000;2000:6-6.
FULL TEXT
|
